Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index; 1 of the 43 sources its claims cite were checked for support.

A neuroprosthesis for tremor management through the control of muscle co-contraction

Open access
Gallego, Juan Álvaro, Rocon, Eduardo, Belda-Lois, Juan Manuel, Pons, José Luis · 2013 · Journal of NeuroEngineering and Rehabilitation

Abstract

BACKGROUND: Pathological tremor is the most prevalent movement disorder. Current treatments do not attain a significant tremor reduction in a large proportion of patients, which makes tremor a major cause of loss of quality of life. For instance, according to some estimates, 65% of those suffering from upper limb tremor report serious difficulties during daily living. Therefore, novel forms for tremor management are required. Since muscles intrinsically behave as a low pass filter, and tremor frequency is above that of volitional movements, the authors envisioned the exploitation of these properties as a means of developing a novel treatment alternative. This treatment would rely on muscle co-contraction for tremor management, similarly to the strategy employed by the intact central nervous system to stabilize a limb during certain tasks. METHODS: We implemented a neuroprosthesis that regulated the level of muscle co-contraction by injecting current at a pair of antagonists through transcutaneous neurostimulation. Co-contraction was adapted to the instantaneous parameters of tremor, which were estimated from the raw recordings of a pair of solid state gyroscopes with a purposely designed adaptive algorithm. For the experimental validation, we enrolled six patients suffering from parkinsonian or essential tremor of different severity, and evaluated the effect of the neuroprosthesis during standard tasks employed for neurological examination. RESULTS: The neuroprosthesis attained significant attenuation of tremor (p<0.001), and reduced its amplitude up to a 52.33±25.48%. Furthermore, it alleviated both essential and parkinsonian tremor in spite of their different etiology and symptomatology. Tremor severity was not a limiting factor on the performance of the neuroprosthesis, although there was a subtle trend towards larger attenuation of more severe tremors. Tremor frequency was not altered during neurostimulation, as expected from the central origin of Parkinson's disease and essential tremor. All patients showed a good tolerance to neurostimulation in terms of comfort and absence of pain, and some spontaneously reported that they felt that tremor was reduced when the neuroprosthesis was activated. CONCLUSIONS: The results presented herein demonstrate that the neuroprosthesis provides systematic attenuation of the two major types of tremor, irrespectively from their severity. This study sets the basis for the validation of the neuroprosthesis as an alternative, non-invasive means for tremor management.

Overview

CoChat Summary

TL;DR

This paper presents a wearable neuroprosthesis that reduces upper-limb tremor by transcutaneous neurostimulation that induces muscle co-contraction at antagonist muscles. In 6 patients with essential tremor or Parkinsonian tremor, it significantly reduced tremor amplitude, with a mean reduction of 52.33±25.48% (p<0.001), without changing tremor frequency.

Key findings

  • In 6 patients (1 female; 2 PD, 4 ET; mean age 68.2±13.8 years; tremor severity 3 to 30 on the Fahn-Tolosa-Marin score), the neuroprosthesis reduced tremor amplitude to 52.33±25.48% of baseline on average.
  • The reduction was statistically significant (p<0.001) and was observed in 26 out of 30 trials.
  • More severe tremors were attenuated to a greater extent (p=0.008), and the trend in attenuation vs. baseline amplitude had a log-log slope of −0.160 with R²=0.243.
  • Tremor frequency was not altered by neurostimulation (p=0.831).

Methods

  • The authors built a wearable neuroprosthesis that delivered transcutaneous neurostimulation to antagonist muscles to increase co-contraction and thereby manipulate joint stiffness and viscosity.
  • Tremor was estimated from solid-state gyroscopes using a two-stage adaptive signal-processing pipeline: a g-h filter to separate voluntary movement, then a WFLC + Kalman filter cascade to track tremor frequency and amplitude.
  • They tested the device in 6 patients with either Parkinson’s disease (n=2) or essential tremor (n=4) during standard neurological tasks; analysis compared trials with vs. without active stimulation using Mann-Whitney tests and a power-spectrum-based attenuation ratio (Ratt).

Limitations

  • The paper states that controller gains were selected manually, and says better automatic gain selection could improve outcomes and might reduce the 4 trials in which tremor worsened.
  • The authors note that muscle accommodation/fatigue during extended use would require adapting controller parameters over time.
  • Evident from the text: the sample was very small (n=6) and heterogeneous, so the findings are promising but limited for generalization.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/1743-0003-10-36

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 NP for tremor management. The concept design (A) envisioned the NP as a textile substrate that integrated the neurostimulation electrodes, the gyroscopes and the control electronics. The final prototype (B) consisted of two pairs of textile supports that incorporated the solid gyroscopes, and off the shelf transcutaneous electrodes. This permitted personalizing the prototype to each patient. In (B), red arrows point at the gyroscopes (placed in the textile supports), and blue arrows at the neurostimulation electrodes (the color code corresponds to that employed for the NP constituents in (A)). The electrodes over the flexor carpi ulnaris and the biceps brachii are not visible in the picture.
Figure 1 NP for tremor management. The concept design (A) envisioned the NP as a textile substrate that integrated the neurostimulation electrodes, the gyroscopes and the control electronics. The final prototype (B) consisted of two pairs of textile supports that incorporated the solid gyroscopes, and off the shelf transcutaneous electrodes. This permitted personalizing the prototype to each patient. In (B), red arrows point at the gyroscopes (placed in the textile supports), and blue arrows at the neurostimulation electrodes (the color code corresponds to that employed for the NP constituents in (A)). The electrodes over the flexor carpi ulnaris and the biceps brachii are not visible in the picture.CC BY · PubMed Central
Figure 2 Rationale behind the tremor suppression approach. Frequency response of a human joint, showing how it is modified by co-contraction of the antagonist muscle pair. The data for the human joint without the neuroprosthesis (black trace) corresponds to the model given in (1) fitted to the parameters identified for the wrist in [39]. The remainder traces represent how the response of the joint is modified by a concurrent increase in viscosity and stiffness (defined as a multiple of the parameters D and K), and correspond to: i) equal increments of DNP and KNP (in multiples of 10, from 10 to 100, shown as blue traces), ii) larger increments of DNP (in multiples of 50, from 50 to 500) than of KNP (in multiples of 10, from 10 to 100, shown as red traces), and iii) larger increments of KNP (in multiples of 50, from 50 to 500) than of DNP (in multiples of 10, from 10 to 100, shown as yellow traces). For all cases, larger values of DNP and KNP cause the response of the joint to have smaller magnitude (as indicated by the arrow in gray).
Figure 2 Rationale behind the tremor suppression approach. Frequency response of a human joint, showing how it is modified by co-contraction of the antagonist muscle pair. The data for the human joint without the neuroprosthesis (black trace) corresponds to the model given in (1) fitted to the parameters identified for the wrist in [39]. The remainder traces represent how the response of the joint is modified by a concurrent increase in viscosity and stiffness (defined as a multiple of the parameters D and K), and correspond to: i) equal increments of DNP and KNP (in multiples of 10, from 10 to 100, shown as blue traces), ii) larger increments of DNP (in multiples of 50, from 50 to 500) than of KNP (in multiples of 10, from 10 to 100, shown as red traces), and iii) larger increments of KNP (in multiples of 50, from 50 to 500) than of DNP (in multiples of 10, from 10 to 100, shown as yellow traces). For all cases, larger values of DNP and KNP cause the response of the joint to have smaller magnitude (as indicated by the arrow in gray).CC BY · PubMed Central
Figure 3 Example of the controller of the NP. The plot shows the estimation of tremor (solid line) and the amplitude of the current applied at the extensors (dashed line) and flexors (dotted line). The instant at which the NP was triggered is signaled with an arrow. Angular velocity is scaled [x 15] for visualization sake; a positive value corresponds to wrist extension.
Figure 3 Example of the controller of the NP. The plot shows the estimation of tremor (solid line) and the amplitude of the current applied at the extensors (dashed line) and flexors (dotted line). The instant at which the NP was triggered is signaled with an arrow. Angular velocity is scaled [x 15] for visualization sake; a positive value corresponds to wrist extension.CC BY · PubMed Central
Figure 4 Examples of reduction of tremor amplitude with the NP. Each subplot in this graphic shows a representative trial for each patient, and compares the amplitude of the tremor before (gray) and after (black) the NP was activated. Top plots represent the data in the time domain, whereas bottom plots represent the same data in the frequency domain (we show the mean power spectral density for the neurostimulation and non-neurostimulation periods). In the time domain, the moments at which the NP was triggered are signaled with an arrow; in the frequency domain, the arrow points at the tremor peak while the NP was activated. Examples correspond to: patient 01 (A), patient 02 (B), patient 03 (C), patient 04 (D), patient 05 (E) and patient 06 (F).
Figure 4 Examples of reduction of tremor amplitude with the NP. Each subplot in this graphic shows a representative trial for each patient, and compares the amplitude of the tremor before (gray) and after (black) the NP was activated. Top plots represent the data in the time domain, whereas bottom plots represent the same data in the frequency domain (we show the mean power spectral density for the neurostimulation and non-neurostimulation periods). In the time domain, the moments at which the NP was triggered are signaled with an arrow; in the frequency domain, the arrow points at the tremor peak while the NP was activated. Examples correspond to: patient 01 (A), patient 02 (B), patient 03 (C), patient 04 (D), patient 05 (E) and patient 06 (F).CC BY · PubMed Central
Figure 5 Summary of all the trials in which the NP was active. The plot shows tremor attenuation computed with Ratt as a function of tremor severity. Each marker stands for a single trial. The plot is interpreted as the further below the dashed line (geometrical locus of Ratt = 100%), the larger the attenuation. Patients are codified as follows: ▿ corresponds to patient 01, □ to patient 02, + to patient 03, ∘ to patient 04, ♢ to patient 05, and △ to patient 06.
Figure 5 Summary of all the trials in which the NP was active. The plot shows tremor attenuation computed with Ratt as a function of tremor severity. Each marker stands for a single trial. The plot is interpreted as the further below the dashed line (geometrical locus of Ratt = 100%), the larger the attenuation. Patients are codified as follows: ▿ corresponds to patient 01, □ to patient 02, + to patient 03, ∘ to patient 04, ♢ to patient 05, and △ to patient 06.CC BY · PubMed Central
Figure 6 Tremor attenuation as function of the trial number. The plot shows how tremor attenuation computed with Ratt varied as more trials were performed, for all patients. Each marker represents a single trial, and the color of the marker corresponds to the severity of the tremor during this trial (before the NP was activated). The color scale is adjusted to the amplitude of each patient’s tremor, and represents trials with mild tremor as cold colors, and with severe tremor as hot colors (see colorbar in the plot). Patients are codified as follows: ▿ corresponds to patient 01, □ to patient 02, + to patient 03, ∘ to patient 04, ♢ to patient 05, and △ to patient 06.
Figure 6 Tremor attenuation as function of the trial number. The plot shows how tremor attenuation computed with Ratt varied as more trials were performed, for all patients. Each marker represents a single trial, and the color of the marker corresponds to the severity of the tremor during this trial (before the NP was activated). The color scale is adjusted to the amplitude of each patient’s tremor, and represents trials with mild tremor as cold colors, and with severe tremor as hot colors (see colorbar in the plot). Patients are codified as follows: ▿ corresponds to patient 01, □ to patient 02, + to patient 03, ∘ to patient 04, ♢ to patient 05, and △ to patient 06.CC BY · PubMed Central
Figure 7 Effect of the NP on tremor frequency. The plot compares tremor frequency with the NP activated (black) and not activated (gray) for each patient (denoted as PXX, where XX is the patient code). Results are shown as mean (circle) ± SD (whiskers) of the mean frequency for the ensemble of all trials.
Figure 7 Effect of the NP on tremor frequency. The plot compares tremor frequency with the NP activated (black) and not activated (gray) for each patient (denoted as PXX, where XX is the patient code). Results are shown as mean (circle) ± SD (whiskers) of the mean frequency for the ensemble of all trials.CC BY · PubMed Central

Verification

Claims the paper makes

1 Valid · 2 Not valid · 23 Not checked · 47 Own results and interpretations

38 more claims

Create a free account to see all 73 claims and to verify the 9 references still open.

See all claims — free account
  • It may state two separate claims as one. 18
  • Probably not a substantial claim. 17

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 65 references

Cited by

See all 81

Metadata

Authors
Gallego, J. Á., Rocon, E., Belda-Lois, J. M., & Pons, J. L.
Affiliations
Consejo Superior de Investigaciones Científicas (ES)
Corresponding author
Gallego, Juan Álvaro
Venue
Journal of NeuroEngineering and Rehabilitation
Published
2013
Volume
10
Issue
1
Pages
36
ISSN
1743-0003 (ISSN-L)
OpenAlex
W2163040354
Cited by
81
References
65
Citations by year
2025: 4 · 2024: 5 · 2023: 8 · 2022: 11 · 2021: 7 · 2020: 5 · 2019: 9 · 2018: 2 · 2017: 8 · 2016: 5 · 2015: 7 · 2014: 6 · 2013: 4
FWCI
4.65
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Journal of NeuroEngineering and Rehabilitation (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
Funders
  • European Commission (ICT-2011, 287739, 224051)
  • Universitat de València
  • Ministerio de Ciencia e Innovación (CSD2009, CSD2009-00067)
  • Consejo Superior de Investigaciones Científicas
Topics
  • Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Motor Control and Adaptation
  • Health Sciences › Medicine › Clinical Neurology › Botulinum Toxin and Related Neurological Disorders
Keywords
pathological tremor, neural prostheses, co-contraction, Parkinson's disease, essential tremor, gyroscope, adaptive algorithms, non-invasive treatment, antagonists
MeSH terms
Adult, Aged, Aged, 80 and over, Algorithms, Transcutaneous Electric Nerve Stimulation, Female, Humans, Male, Middle Aged, Muscle Contraction, Parkinson Disease, Muscle, Skeletal, Essential Tremor, Neural Prostheses

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A neuroprosthesis for tremor management through the control of muscle co-contraction. https://app.cochat.ai/papers/10.1186/1743-0003-10-36
The paper
Gallego, J. Á., Rocon, E., Belda-Lois, J. M., & Pons, J. L. (2013). A neuroprosthesis for tremor management through the control of muscle co-contraction. Journal of NeuroEngineering and Rehabilitation. https://doi.org/10.1186/1743-0003-10-36

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.